Innovative Biomarker Solutions

Myriad RBM provides industry-leading protein biomarker products and services based on our Multi-Analyte Profile (MAP) platform. Use our products and services to advance your research, drug and diagnostic development projects.

CLINICAL TRIALS

Myriad RBM is a CLIA certified laboratory providing researchers with reproducible, quantitative immunoassay data for hundreds of proteins from a single drop of blood serum or plasma. Services support pharmacodynamic, prognostic, and predictive clinical studies.

CustomMAP Builder

Customize a set of multiplexed protein biomarkers specific to a drug mechanism of action for accurate and reproducible pharmacodynamic data.

HumanMAPs

Human MAPs provide insight into multiple pathways to help better understand the underlying disease biology and therapeutic effects.

TruCulture

A whole-blood collection and leukocyte culture system for standardized, pharmacodynamic immune-phenotyping studies.

Ultrasensitive Immunoassays

Quantify extremely low levels of protein analytes in serum or plasma with single molecule array (Simoa™) immunoassays.

DISCOVERY

Myriad RBM’s MAP (Multi-Analyte Profile) service platform provides reproducible, quantitative measurement of over 300 proteins covering dozens of biochemical and signaling pathways. Discover pharmacodynamic biomarker patterns to guide your clinical trial and companion diagnostic development programs.

The RBM Approach

Cast a wide net, identify, then validate biomarkers from key pathways to make the drug discovery and development process more efficient and effective.

Focused MAPs

MAPs organized into therapy indications for a more targeted approach with reduced sample volume requirements.

CustomMAP Builder

Select a combination of biomarkers from a menu of 300 immunoassays to target those central to your drug development programs.

Ultrasensitive Immunoassays

High quality, single molecule array (Simoa™) services that offer drug developers an unparalleled approach to clinical research.

765

Publications Cited

300

Quantitative Immunoassays

32396468

Data Points Generated

498952

Samples Tested

LATEST NEWS